ePrivacy and GPDR Cookie Consent by TermsFeed Generator

Detail of the clinical trial

Title of the trial A phase I/II study of 177Lu-HH1 (BetalutinTM) radioimmunotherapy for treatment of relapsed CD37+ non-Hodgkin lymphoma
EudraCT number 2011-000033-36
Protocol number LYMRIT-37-01
Sponsor Nordic Nanovector AS,Kjelsasveien 168B,Oslo,NO-0884, Norway
Indications Hemato-oncology
Diagnosis non-Hodgkin lymphoma
Population in clinical trial Adults (18-65 years)
Elderly ( > 65 years)
Male
Female
Patients
Year of receiving the request to Institute (SÚKL) 2014
Date of approval by Institute (SÚKL) 2.4.2015
Date of approval by EC 19.1.2015
Date of initiation CT in ČR 6.4.2016
Date of ending CT in ČR 20.7.2022
Notice
Sites FNKV ,Interní hematologická klinika,Šrobárova 10,Praha 10,100 34 (discontinued)
FNsP Ostrava,Klinika hematoonkologie,17 listopadu 1790,Ostrava, Poruba,708 52
FN Olomouc,Hemato-onkologická klinika,I.P. Pavlova 6,Olomouc,779 00
FN Brno,Interní hematologická a onkologická klinika,Jihlavská 20,Brno,625 00 (discontinued)
VFN v Praha,I. interní klinika - klinika hematologie,U Nemocnice 2,Praha 2,128 08 (discontinued)

‹‹ Back to list